Key Challenges for In Vitro Testing of Tobacco Products for Regulatory Applications: Recommendations for the In Vitro Mouse Lymphoma Assay
Alternatives to Laboratory Animals · 2024
DOI: 10.1177/02611929231219153 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alternatives to Laboratory Animals, 2024. Verfasst von Ian Crooks und 9 weiteren Autor:innen. Beteiligte Einrichtung: B.A.T. (Investments) Limited, Southampton, UK. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Tobacco Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Institute for In Vitro Sciences, Education and Outreach Program, U.S. Food and Drug Administration.
Abstract (Originalsprache)
The Institute for In Vitro Sciences (IIVS) is sponsoring a series of workshops to develop recommendations for optimal scientific and technical approaches for conducting in vitro assays to assess potential toxicity within and across traditional tobacco and various tobacco and nicotine next-generation products (NGPs), including Heated Tobacco Products (HTPs) and Electronic Nicotine Delivery Systems (ENDS). This report was developed by a working group composed of attendees of the seventh IIVS workshop, ‘Approaches and recommendations for conducting the mouse lymphoma gene mutation assay (MLA) and introduction to in vitro disease models’, which was held virtually on 21–23 June 2022. This publication provides a background overview of the MLA, and includes the description of assay conduct and data interpretation, key challenges and recommended best practices for evaluating tobacco and nicotine products, with a focus on the evaluation of NGPs, and a summary of how the assay has been used to evaluate and compare tobacco and nicotine products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- B.A.T. (Investments) Limited, Southampton, UK.
- Labcorp Early Development Services, Harrogate, UK.
- Institute for In Vitro Sciences, Gaithersburg, MD, USA.
- National Center for Toxicological Research, Jefferson, AR, USA.
- Philip Morris International R&D, Philip Morris Products S.A., Neuchatel, Switzerland.
- Oekolab Ges. F. Umweltanalytik, A member of the JT International Group of Companies, Vienna, Austria.
ORCID-Profile: Elisabeth Weber
Förderung
- Institute for In Vitro Sciences, Education and Outreach Program
- U.S. Food and Drug Administration
Zitieren
APA
Crooks, I., Clements, J., Curren, R., Guo, X., Hollings, M., Lloyd, M., Smart, D., Thorne, D., Weber, E., & Moore, M. (2024). Key Challenges for In Vitro Testing of Tobacco Products for Regulatory Applications: Recommendations for the In Vitro Mouse Lymphoma Assay. Alternatives to Laboratory Animals. https://doi.org/10.1177/02611929231219153
Vancouver
Crooks I, Clements J, Curren R, Guo X, Hollings M, Lloyd M, et al. Key Challenges for In Vitro Testing of Tobacco Products for Regulatory Applications: Recommendations for the In Vitro Mouse Lymphoma Assay. Alternatives to Laboratory Animals. 2024. doi:10.1177/02611929231219153
BibTeX
@article{Crooks2024,
author = {Crooks, Ian and Clements, Julie and Curren, Rodger and Guo, Xiaoqing and Hollings, Michael and Lloyd, Mel and Smart, Daniel and Thorne, David and Weber, Elisabeth and Moore, Martha},
title = {Key Challenges for In Vitro Testing of Tobacco Products for Regulatory Applications: Recommendations for the In Vitro Mouse Lymphoma Assay},
journal = {Alternatives to Laboratory Animals},
year = {2024},
doi = {10.1177/02611929231219153}
}
EUVIMED